van der Pijl, Robbert J.
Domenighetti, Andrea A.
Sheikh, Farah
Ehler, Elisabeth
Ottenheijm, Coen A. C.
Lange, Stephan http://orcid.org/0000-0001-9361-6602
Funding for this research was provided by:
national heart, lung, and blood institute (HL128457, HL152251, HL121500, HL142251, HL145534)
hjärt-lungfonden (20180199)
novo nordisk fonden (NNF20OC0062812)
british heart foundation
medical research council
department of defense (W81XWH1810380)
cures within reach
pedal-with-pete foundation with the american academy of cerebral palsy and developmental medicine
Article History
Received: 27 July 2021
Accepted: 23 August 2021
First Online: 9 September 2021
Declarations
:
: All procedures involving genetically modified animals have been approved by the institutional oversight committee at UC San Diego.
: Farah Sheikh is a cofounder of Papillon Therapeutics Inc. All other co-authors (R.v.d.P., A.D., C.O., E.E. and S.L.) declare that they have no conflicts of interest.